Indivior Pharmaceuticals (INDV) Interest & Investment Income (2022 - 2025)
Historic Interest & Investment Income for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $6.0 million.
- Indivior Pharmaceuticals' Interest & Investment Income rose 2000.0% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $23.0 million for FY2024, which is 4651.16% down from last year.
- Per Indivior Pharmaceuticals' latest filing, its Interest & Investment Income stood at $6.0 million for Q3 2025, which was up 2000.0% from $6.0 million recorded in Q2 2025.
- Over the past 5 years, Indivior Pharmaceuticals' Interest & Investment Income peaked at $12.0 million during Q3 2023, and registered a low of $2.0 million during Q2 2022.
- Moreover, its 4-year median value for Interest & Investment Income was $6.0 million (2022), whereas its average is $7.2 million.
- In the last 5 years, Indivior Pharmaceuticals' Interest & Investment Income skyrocketed by 45000.0% in 2023 and then crashed by 5833.33% in 2024.
- Over the past 4 years, Indivior Pharmaceuticals' Interest & Investment Income (Quarter) stood at $10.0 million in 2022, then changed by 0.0% to $10.0 million in 2023, then tumbled by 50.0% to $5.0 million in 2024, then rose by 20.0% to $6.0 million in 2025.
- Its last three reported values are $6.0 million in Q3 2025, $6.0 million for Q2 2025, and $4.0 million during Q1 2025.